Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  fluorescent protease-activated peptide AVB-620
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Status: Not yet active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: AVB620-C-002, NCI-2017-01105, NCT03113825
Start Over